Bristol-Myers Squibb


Understanding HCM

Our Pipeline

Bristol Myers Squibb

Mavacamten MOA

This site is intended for US Health Care Professionals only.

HCM: How to Know the Masquerader When You See it

Approximately 1 in 500 to 1 in 200 people in the US may have hypertrophic cardiomyopathy (HCM), a serious, progressive, often heritable myocardial disease.1 An estimated 85% remain undiagnosed.2

HCM symptoms—including dyspnea, fatigue, chest pain, palpitations and syncope—can mimic other cardiovascular and pulmonary conditions.1,3-5 Cardiac imaging, including echocardiography, is the key to a differential diagnosis.1

Click here to learn more about HCM

HCM & HF in the Spotlight at the HFSA Annual Scientific Meeting 2021

Add the following HCM session to your schedule:

Saturday, September 11, 2021

7:30 PM - 9:00 PM MST

Improving the recognition of HCM and its progression to heart failure: An expert review of challenging cases

Presented by

David Fermin MD, FACC, FHFSA

David Fermin, MD, FACC, FHFSA

Matthew Martinez, MD

Matthew Martinez, MD

Hypertrophic cardiomyopathy (HCM) is tricky to recognize and mimics symptoms of several other conditions



Key Diagnostic Takeaways for Identifying HCM

Download now

Sign up to learn more about HCM from BMS and other promotional materials that may be of interest to you.

1Ommen SR et al. J Am Coll Cardiol. 2020;76(25): e159-e240.

2Maron MS et al. Am J Cardiol. 2016;117:1651e1654.

3Sankaranarayanan R et al. Arrhythm Electrophysiol Rev. 2013;2(1):36-40

4Mayo Clinic. Asthma: symptoms and causes. Accessed February 13, 2020.

5Mayo Clinic. COPD: symptoms and causes. Accessed February 13, 2020.

Bristol-Myers Squibb

© 2021 MyoKardia, Inc, a wholly owned subsidiary of Bristol-Myers Squibb™. All rights reserved. CV-US-2100443 08/21